Catalent Expands Clinical Supply Capabilities

Mar 02, 2018
By BioPharm International Editors

Catalent Pharma Solutions announced on Feb. 28, 2018 the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. The expansion added GMP space for secondary packaging, doubled ambient storage, and quadrupled cold storage capacity at the site. The site, which has almost tripled in size since opening in 1998, measures almost 20,000-sq. ft. and is described by the company as a key strategic hub in its Asia-Pacific network and global clinical supply business.

“We are particularly pleased to have completed the expansion in a year that marks the 20th anniversary of what was Catalent’s first facility in the Asia-Pacific region,” said Bernie Clark, VP Marketing, Catalent Clinical Supply Services in a company press release. “Supported by many long-serving employees, the Singapore site has undergone tremendous growth over the past two decades and now routinely distributes to 18 countries in the region.”

The company has facilities in the United States, United Kingdom, Germany, Japan, and China, and more than 50 audited depots.

Source: Catalent Pharma Solutions

 

native1_300x100
lorem ipsum